The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
In a move that strengthens its footprint in the high-growth healthcare sector, H.B. Fuller announced the acquisition of Advanced Medical Solutions (AMS) for £715 million, according to reports. The news sent AMS shares surging about 16% in the following trading session, reflecting market approval of the acquisition premium.
The deal aligns with H.B. Fuller's strategy to expand in high-margin medical adhesives, as Advanced Medical Solutions brings a strong portfolio of wound care and surgical adhesive products. Neither company has commented on financing or expected synergies, but analysts note the acquisition enhances H.B. Fuller's manufacturing capabilities in Europe and opens new markets.
Sign in to access this content
Sign InInvestors are now focused on the completion stages, which require regulatory and shareholder approvals. The deal is expected to close by the second half of 2026, while the market will watch for any developments regarding financing terms and integration plans. Shares remain under scrutiny, though a competing bid is considered unlikely at this stage.